BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8789500)

  • 1. Gastrointestinal endocrine cancers and nodal metastasis: biologic significance and therapeutic implications.
    Peplinski GR; Norton JA
    Surg Oncol Clin N Am; 1996 Jan; 5(1):159-71. PubMed ID: 8789500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of unresectable malignant endocrine tumors of the pancreas.
    Modlin IM; Lewis JJ; Ahlman H; Bilchik AJ; Kumar RR
    Surg Gynecol Obstet; 1993 May; 176(5):507-18. PubMed ID: 8386860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
    Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
    Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
    [No Abstract]   [Full Text] [Related]  

  • 5. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery on neuroendocrine tumours.
    Akerström G; Hellman P
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal carcinomatosis in patients with digestive endocrine tumors.
    Vasseur B; Cadiot G; Zins M; Fléjou JF; Belghiti J; Marmuse JP; Vilgrain V; Bernades P; Mignon M; Ruszniewski P
    Cancer; 1996 Oct; 78(8):1686-92. PubMed ID: 8859181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of carcinoid tumors in the gastrointestinal tract].
    Nishikura K; Watanabe H; Iwafuchi M; Ajioka Y; Mukai G
    Gan To Kagaku Ryoho; 2003 May; 30(5):606-13. PubMed ID: 12795090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
    Comaru-Schally AM; Schally AV
    Int J Oncol; 2005 Feb; 26(2):301-9. PubMed ID: 15645113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed staging system for gastrointestinal carcinoid tumors.
    Landry CS; McMasters KM; Scoggins CR; Martin RC
    Am Surg; 2008 May; 74(5):418-22. PubMed ID: 18481499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
    Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
    Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgery for metastatic liver neuroendocrine tumors.
    Norton JA; Warren RS; Kelly MG; Zuraek MB; Jensen RT
    Surgery; 2003 Dec; 134(6):1057-63; discussion 1063-5. PubMed ID: 14668741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine tumors of the extrahepatic bile ducts. Pathological and clinical aspects, surgical management and outcome.
    El Rassi ZS; Mohsine RM; Berger F; Thierry P; Partensky CC
    Hepatogastroenterology; 2004; 51(59):1295-300. PubMed ID: 15362737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.
    Norton JA
    Best Pract Res Clin Gastroenterol; 2005 Aug; 19(4):577-83. PubMed ID: 16183528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare surgical case of multiple liver resections for recurrent liver metastases from pancreatic gastrinoma: liver and vena cava resection.
    Pachera S; Yokoyama Y; Nishio H; Oda K; Ebata T; Igami T; Abe T; Shingu Y; Nagino M
    J Hepatobiliary Pancreat Surg; 2009; 16(5):692-8. PubMed ID: 19267257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to hepatic involvement by endocrine tumors of the gastrointestinal tract.
    Stockmann F; Creutzfeldt W
    Semin Liver Dis; 1988 Aug; 8(3):254-62. PubMed ID: 2906761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM
    Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.